格隆汇5月12日丨英派药业-B(07630.HK)公告，公司全球发售41,977,000股H股，每股H股20.10港元，所得款项净额7.6亿港元。香港公开发售股份数目占全球发售股份数目10%，获认购2,282.4倍；国际发售股份数目占全球发售股份90%，获认购倍24.58倍。 假设全球发售于2026年5月13日(星期三)上午八时正或之前(香港时间)成为无条件，预期H股将于2026年5月13日(星期三)上午九时正(香港时间)开始在联交所买卖。H股将以200股H股为一手买卖单位进行交易，H股的股份代号为7630。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.